Biomark Diagnostics Inc. (BMKDF)
OTCMKTS · Delayed Price · Currency is USD
0.134
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST

Biomark Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Market Capitalization
10181113249
Upgrade
Market Cap Growth
-6.61%60.82%-9.22%-48.38%157.32%281.16%
Upgrade
Enterprise Value
111913142510
Upgrade
Last Close Price
0.130.220.140.170.330.13
Upgrade
PS Ratio
127.40152.12100.50356.91-50.91
Upgrade
PB Ratio
-19.46-40.73-13.42-24.67-386.98-30.52
Upgrade
EV/Sales Ratio
103.67161.35110.73393.16-51.81
Upgrade
Debt / Equity Ratio
-1.44-2.54-1.44-3.09-12.71-0.02
Upgrade
Asset Turnover
0.210.180.140.04-0.78
Upgrade
Quick Ratio
0.070.160.060.310.980.58
Upgrade
Current Ratio
0.070.160.080.331.000.58
Upgrade
Return on Assets (ROA)
-168.69%-117.29%-104.38%-66.19%-80.77%-220.06%
Upgrade
Return on Capital (ROIC)
-325.61%-148.56%-125.52%-71.12%-259.30%-
Upgrade
Earnings Yield
-9.78%-5.75%-11.94%-9.27%-3.57%-9.07%
Upgrade
FCF Yield
-5.85%-3.97%-5.96%-8.06%-2.64%-3.39%
Upgrade
Buyback Yield / Dilution
-0.88%-2.97%-6.22%-6.31%-2.82%-8.16%
Upgrade
Total Shareholder Return
-0.88%-2.97%-6.22%-6.31%-2.82%-8.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.